Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa
Child's Nervous System · 2026
DOI: 10.1007/s00381-025-07110-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Child's Nervous System, 2026. Verfasst von Edmund Kibuuka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Drug Resistant Epilepsy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of the Witwatersrand.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
To evaluate the clinical outcomes of vagal nerve stimulation (VNS) in children with drug refractory epilepsy (DRE) in a Sub-Saharan setting.
Methods
We retrospectively reviewed the data of 93 paediatric patients with DRE who underwent VNS insertion between January 2008 and December 2022. Patient demographics, aetiology of epilepsy and seizure data were analyzed. Seizure outcomes were measured using the Engel, McHugh, and Hague scores. Statistical analysis was performed using the Chi-square test, T-tests, and Spearman’s correlation.
Results
Of the 93 patients who underwent VNS implantation 60% achieved a seizure reduction of at least 50%. Demographic factors associated with improved seizure control included age at implantation ( p < 0.001) and shorter duration from first reported seizure to implantation ( p < 0.001). The mean time to response was 6.9 months. The McHugh scale showed a significant association between the length of follow up and VNS response. Adverse effects of VNS insertion were limited. Our outcome data and complication rates were in line with previous studies from the developed world. Challenges unique to our population included delay from diagnosis to referral; on average, there was a 5-year period from diagnosis of DRE to referral to our center. In addition to the large population and our extensive geographic referral pattern, we identified that a key factor in delayed referral to our center was due to a poor awareness, amongst both caregivers and referring clinicians of VNS as a treatment option for DRE.
Conclusion
VNS is a safe and effective adjunctive treatment for children with DRE in the Sub-Saharan population, with results comparable to centers in the developed world. In our cohort of patients, the McHugh scale appeared to be a more sensitive tool for assessing and tracking VNS response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Paediatric Neurosurgery, Nelson Mandela Children's Hospital, Johannesburg, South Africa.
- Department of Neurosurgery, University of the Witwatersrand, Johannesburg, South Africa. Jason.labuschagne@icloud.com.
- Department of Paediatric Neurosurgery, Nelson Mandela Children's Hospital, Johannesburg, South Africa. Jason.labuschagne@icloud.com.
- Nelson Mandela Children's Hospital, 6 Jubilee Road, Parktown, Johannesburg, 2193, South Africa. Jason.labuschagne@icloud.com.
Förderung
- University of the Witwatersrand
Zitieren
APA
Kibuuka, E., Mutyaba, D., Ouma, J., & Labuschagne, J. (2026). Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa. Child's Nervous System. https://doi.org/10.1007/s00381-025-07110-x
Vancouver
Kibuuka E, Mutyaba D, Ouma J, Labuschagne J. Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa. Child's Nervous System. 2026. doi:10.1007/s00381-025-07110-x
BibTeX
@article{Kibuuka2026,
author = {Kibuuka, Edmund and Mutyaba, Denis and Ouma, John and Labuschagne, Jason},
title = {Evaluation of the outcomes of vagal nerve stimulation in children with drug-refractory epilepsy in South Africa},
journal = {Child's Nervous System},
year = {2026},
doi = {10.1007/s00381-025-07110-x}
}
EUVIMED